Atlas Trials

KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer

Clinical trial NCT03946202 · RECRUITING

Trial details

NCT number
NCT03946202
Sponsor
Institute of Cancer Research, United Kingdom
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2020-06-16
Primary completion
2028-06-30
Enrollment
184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.